Cargando…

CUEDC2 Contributes to Cisplatin-Based Chemotherapy Resistance in Ovarian Serious Carcinoma by Regulating p38 MAPK Signaling

Chemoresistance remains an obstacle to the successful treatment of ovarian carcinoma. CUE domain-containing 2 (CUEDC2) plays critical roles in tumor genesis and overexpresses in many solid cancers, including ovarian serous carcinoma. In previous study, we found that overexpression of CUEDC2 might be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Aichun, Li, Jinhang, Zhou, Tao, Li, Tao, Cai, Hong, Shi, Huaiyin, Liu, Aijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547988/ https://www.ncbi.nlm.nih.gov/pubmed/31205536 http://dx.doi.org/10.7150/jca.29889

Ejemplares similares

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

CUEDC2 modulates cardiomyocyte oxidative capacity by regulating GPX1 stability
por: Jian, Zhao, et al.
Publicado: (2016)

Expression of CUEDC2 in colorectal cancer with different invasion and migration abilities
por: Hu, Shidong, et al.
Publicado: (2019)

CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
por: Sun, Longhua, et al.
Publicado: (2015)

CUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathway
por: Li, Feng, et al.
Publicado: (2017)

Downregulation of CUEDC2 prevents doxorubicin-induced cardiotoxicity in H9c2 cells
por: Zhang, Xianpu, et al.
Publicado: (2018)

CUEDC1 inhibits epithelial-mesenchymal transition via the TβRI/Smad signaling pathway and suppresses tumor progression in non-small cell lung cancer
por: Cui, Yue, et al.
Publicado: (2020)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
por: Han, Shuyan, et al.
Publicado: (2022)

Feedback inhibition of CREB signaling by p38 MAPK contributes to the negative regulation of steroidogenesis
por: Li, Jiaxin, et al.
Publicado: (2017)

TGF-β1 contributes to CD8(+) Treg induction through p38 MAPK signaling in ovarian cancer microenvironment
por: Wu, Meng, et al.
Publicado: (2016)

CUEDC2 controls osteoblast differentiation and bone formation via SOCS3–STAT3 pathway
por: Kim, Jung-Woo, et al.
Publicado: (2020)

CUEDC2 ablation enhances the efficacy of mesenchymal stem cells in ameliorating cerebral ischemia/reperfusion insult
por: Huang, Yan, et al.
Publicado: (2021)

Screening and Validation of p38 MAPK Involved in Ovarian Development of Brachymystax lenok
por: Huang, Tianqing, et al.
Publicado: (2022)

CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia
por: Wu, Qing-Yun, et al.
Publicado: (2018)

Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway
por: Liu, Yingzhao, et al.
Publicado: (2022)

Activation of p38MAPK Contributes to Expanded Polyglutamine-Induced Cytotoxicity
por: Tsirigotis, Maria, et al.
Publicado: (2008)

Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway
por: Yu, Haiting, et al.
Publicado: (2022)

FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
por: Zhu, Wei, et al.
Publicado: (2023)

p38 MAPK Signaling in Osteoblast Differentiation
por: Rodríguez-Carballo, Eddie, et al.
Publicado: (2016)

Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway
por: Yong, Lei, et al.
Publicado: (2018)

Roles of p38 MAPK signalling in intervertebral disc degeneration
por: Shi, Zheng‐wei, et al.
Publicado: (2023)

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015)

Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC
por: Galan-Moya, Eva M., et al.
Publicado: (2011)

Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
por: Guo, Xianling, et al.
Publicado: (2008)

p38MAPK and Chemotherapy: We Always Need to Hear Both Sides of the Story
por: García-Cano, Jesús, et al.
Publicado: (2016)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
por: Jia, Jinghui, et al.
Publicado: (2020)

Long Noncoding RNA AROD Inhibits Host Antiviral Innate Immunity via the miR-324-5p–CUEDC2 Axis
por: Zhang, Zixiao, et al.
Publicado: (2023)

Cutaneous metastasis of carcinomatous component of ovarian carcinosarcoma: A case report and review of the literature
por: Li, Jinhang, et al.
Publicado: (2022)

Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
por: Du, Juan, et al.
Publicado: (2017)

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway
por: Zeng, Xiaofei, et al.
Publicado: (2020)

p38MAPK Signaling Pathway in Osteoarthritis: Pathological and Therapeutic Aspects
por: Li, Zongchao, et al.
Publicado: (2022)

p38 MAPK, microglial signaling, and neuropathic pain
por: Ji, Ru-Rong, et al.
Publicado: (2007)

Crosstalk between p38 MAPK and GR Signaling
por: Zeyen, Lisa, et al.
Publicado: (2022)

The role and mechanism of biological collagen membranes in repairing cartilage injury through the p38MAPK signaling pathway
por: Yuan, Li-Bo, et al.
Publicado: (2023)

Paclitaxel and SN‐38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down‐regulating the Influx and Efflux System of Cisplatin
por: Komuro, Yuuki, et al.
Publicado: (2001)

Putting the Rit in cellular resistance: Rit, p38 MAPK and oxidative stress
por: Cai, Weikang, et al.
Publicado: (2013)

Knockdown of Heparanase Suppresses Invasion of Human Trophoblasts by Activating p38 MAPK Signaling Pathway
por: Che, Guanglu, et al.
Publicado: (2018)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0trhlbr454fmq35mbpe40hib7v